GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Enterprise Value

Indo US Bio-Tech (NSE:INDOUS) Enterprise Value : ₹7,689.5 Mil (As of Dec. 12, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Indo US Bio-Tech Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Indo US Bio-Tech's Enterprise Value is ₹7,689.5 Mil. Indo US Bio-Tech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was ₹134.9 Mil. Therefore, Indo US Bio-Tech's EV-to-EBIT ratio for today is 57.00.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Indo US Bio-Tech's Enterprise Value is ₹7,689.5 Mil. Indo US Bio-Tech's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₹142.5 Mil. Therefore, Indo US Bio-Tech's EV-to-EBITDA ratio for today is 53.95.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Indo US Bio-Tech's Enterprise Value is ₹7,689.5 Mil. Indo US Bio-Tech's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹847.7 Mil. Therefore, Indo US Bio-Tech's EV-to-Revenue ratio for today is 9.07.


Indo US Bio-Tech Enterprise Value Historical Data

The historical data trend for Indo US Bio-Tech's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Enterprise Value Chart

Indo US Bio-Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Indo US Bio-Tech Quarterly Data
Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Mar23 Sep23 Mar24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 6,043.22

Competitive Comparison of Indo US Bio-Tech's Enterprise Value

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech's Enterprise Value Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Enterprise Value falls into.



Indo US Bio-Tech Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Indo US Bio-Tech's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as

Indo US Bio-Tech's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo US Bio-Tech  (NSE:INDOUS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Indo US Bio-Tech's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=7689.488/134.911
=57.00

Indo US Bio-Tech's current Enterprise Value is ₹7,689.5 Mil.
Indo US Bio-Tech's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹134.9 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Indo US Bio-Tech's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=7689.488/142.534
=53.95

Indo US Bio-Tech's current Enterprise Value is ₹7,689.5 Mil.
Indo US Bio-Tech's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹142.5 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Indo US Bio-Tech's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=7689.488/847.703
=9.07

Indo US Bio-Tech's current Enterprise Value is ₹7,689.5 Mil.
Indo US Bio-Tech's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹847.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo US Bio-Tech Enterprise Value Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo US Bio-Tech Business Description

Comparable Companies
Traded in Other Exchanges
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines